Beijing Tong Ren Tang Chinese Medicine Co (HK:3613) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Beijing Tong Ren Tang Chinese Medicine Co. has renewed its procurement agreement with Tong Ren Tang Ltd. for Angong Niuhuang Wan Powder, extending the arrangement until mid-2027. This renewal involves connected transactions under Hong Kong’s listing rules, requiring reporting and annual review but not independent shareholder approval. The agreement ensures continued supply of essential raw materials for the company’s production needs, maintaining its market presence.
For further insights into HK:3613 stock, check out TipRanks’ Stock Analysis page.
